4512 On Other Exchanges
Symbol
Exchange
4512 is not on other exchanges.

wakamoto pharm co ltd (4512) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for WAKAMOTO PHARM CO LTD (4512)

Related News

No related news articles were found.

wakamoto pharm co ltd (4512) Related Businessweek News

No Related Businessweek News Found

wakamoto pharm co ltd (4512) Details

Wakamoto Pharmaceutical Co., Ltd. manufactures and sells ethical and non-prescription drugs in Japan. It offers Strong Wakamoto, a gastrointestinal drug for digestion, controlling intestinal function, and nutritional supply. The company was formerly known as Society for Nutrition and Raising Children Co., Ltd. and changed its name to Wakamoto Pharmaceutical Co., Ltd. in July 1943. Wakamoto Pharmaceutical Co., Ltd. was founded in 1929 and is headquartered in Tokyo, Japan.

403 Employees
Last Reported Date: 06/25/12
Founded in 1929

wakamoto pharm co ltd (4512) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

wakamoto pharm co ltd (4512) Key Developments

Wakamoto Pharmaceutical Co., Ltd. to Report Q2, 2017 Results on Nov 02, 2016

Wakamoto Pharmaceutical Co., Ltd. announced that they will report Q2, 2017 results on Nov 02, 2016

Wakamoto Pharmaceutical Co., Ltd. to Report Q1, 2017 Results on Aug 03, 2016

Wakamoto Pharmaceutical Co., Ltd. announced that they will report Q1, 2017 results on Aug 03, 2016

Wakamoto Pharmaceutical Co., Ltd., Annual General Meeting, Jun 22, 2016

Wakamoto Pharmaceutical Co., Ltd., Annual General Meeting, Jun 22, 2016.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4512 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4512.
View Industry Companies
 

Industry Analysis

4512

Industry Average

Valuation 4512 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.6x
Price/Book 0.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact WAKAMOTO PHARM CO LTD, please visit www.wakamoto-pharm.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.